In this study, our findings highlight that dual targeting macrophage and microglia infiltration using BAPN and SR9009 coupled with anti-PD1 therapy produces robust antitumor effect and leads to a sustained long-term antitumor memory response in PTEN-deficient GBM mouse models. This evidence concerns the gene PTEN and glioblastoma.